NCT00464373 - Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions

Chronic Prostatitis With Chronic Pelvic Pain SyndromeProstatitis

Interventions

DRUG

Botulinum Toxin Type A

Single intrasphincteric injection at the 3,6,9, and 12 o'clock positions of the external urethral sphincter (1 ml of drug solution each)

DRUG

Placebo

4ml NaCl 0.9%

Trial Locations (1)

Department of Urology, Cantonal Hospital of St. Gallen, Sankt Gallen